Equator Pharmaceutical Private Limited

Equator Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U82920KA2023PTC180632 Incorporated 06 November 2023 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹20.38 Lakh
Latest filing
Net loss · FY 2025
₹72,134
Net margin -3.5%
EBITDA · FY 2025
-₹15,144
EBITDA margin -0.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Equator Pharmaceutical Private Limited

Data last updated:

Equator Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 November 2023.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U82920KA2023PTC180632.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manju Devi and Deepak Choudhary.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.38 Lakh. For the same year it recorded a net loss of ₹72,134 (net margin -3.5%) and EBITDA of -₹15,144 (EBITDA margin -0.7%).

Company Details of Equator Pharmaceutical Private Limited
CIN U82920KA2023PTC180632
Registration Number 180632
Incorporation Date 06 November 2023
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Wework Prestige Central, 36 Infantry Road, Bangalore, Karnataka, India – 560001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Equator Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Equator Pharmaceutical Private Limited report

Financials, compliance, directors, charges, ownership and filings for Equator Pharmaceutical Private Limited in one report.

Financials from FY 2024 Directors & ownership Charges & compliance

Financials of Equator Pharmaceutical Private Limited FY 2025 filings available

Equator Pharmaceutical Private Limited reported revenue of ₹20.38 Lakh for FY 2025.

Revenue · FY 2025
₹20.38 Lakh
Net loss · FY 2025
₹72,134 margin -3.5%
EBITDA · FY 2025
-₹15,144 margin -0.7%

Financial Statement Summary of Equator Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA-₹15,144••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)-₹72,134••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of Equator Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin-0.7%••••
Net Profit Margin-3.5%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Equator Pharmaceutical are in the company report.

Premium access

Financial statements from FY 2024

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Equator Pharmaceutical Private Limited

Equator Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Manju DeviDirector06 Nov 20232 Years 11 MonthsCurrent
Deepak ChoudharyDirector06 Nov 20232 Years 11 MonthsCurrent

Charges & Borrowings of Equator Pharmaceutical Private Limited

Equator Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Equator Pharmaceutical Private Limited

Employment history and EPFO contributions of people linked to Equator Pharmaceutical.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Equator Pharmaceutical Private Limited

Equator Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Deepak Choudhary was appointed as Director on 06 Nov 2023.

AGM
Equator Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Equator Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Deepak Choudhary was appointed as Director.
Appointed
Manju Devi was appointed as Director.
Incorporation
06 Nov 2023
Equator Pharmaceutical Private Limited was registered on 06 Nov 2023 with Roc Bangalore & aged 2 years 11 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Equator Pharmaceutical Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Equator Pharmaceutical Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Equator Pharmaceutical Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Equator Pharmaceutical Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Equator Pharmaceutical Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Equator Pharmaceutical Private Limited

Equator Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 November 2023 (3+ years old) and is registered under CIN U82920KA2023PTC180632.

Equator Pharmaceutical reported revenue of ₹20.38 Lakh for FY 2025.

Equator Pharmaceutical has 2 current directors:

Equator Pharmaceutical reported a net loss of ₹72,134 (net margin -3.5%) and EBITDA of -₹15,144 (EBITDA margin -0.7%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Equator Pharmaceutical is U82920KA2023PTC180632. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Equator Pharmaceutical was incorporated on 06 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.

Deepak Choudhary was appointed as Director on 06 Nov 2023. Manju Devi was appointed as Director on 06 Nov 2023.

The registered office of Equator Pharmaceutical is at Wework Prestige Central, 36 Infantry Road, Bangalore, Karnataka, India – 560001.

Equator Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Equator Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available